| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |